aspirin and lisinopril

aspirin has been researched along with lisinopril in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (11.11)	18.2507
2000's	13 (36.11)	29.6817
2010's	15 (41.67)	24.3611
2020's	4 (11.11)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Ekins, S; Williams, AJ; Xu, JJ	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Dietz, R; Nagel, F; Osterziel, KJ	2
Giles, TD	1
Bookstaver, D; Hilburn, RB; Whitlock, WL	1
Brodskaia, SA; Ivanov, SN; Savenkov, MP	1
Akula, A; Kota, MK; Potharaju, S; Veeravalli, KK	1
Balani, DK; Dubey, K; Pillai, KK	1
Bergmann, JF; Caulin, C; Cohen-Solal, A; Habib, A; Jondeau, G; Kevorkian, JP; Knellwolf, AL; Lebret, M; Levy, B; Mahé, I; Meune, C; Mourad, JJ; Simoneau, G	1
Akula, A; Veeravalli, KK	1
Kumar, V; Shah, RP; Singh, S	1
Kumar, V; Malik, S; Singh, S	1
Thompson, D; Warren, A; Yang, G	1
Capitanini, A; Rosellini, M; Rossi, A; Tavolaro, A	1
Kerchner, K; Sangüeza, OP; Walsh, SN	1
Dissanayake, WP; Furberg, CD; Gunaratne, PS; Jayasingne, IK; Mendis, S; Soliman, EZ; Somasundaram, NP	1
Lee, R	1
Bots, ML; Grobbee, DE; Lafeber, M; Rodgers, A; Spiering, W; Thom, S; Visseren, FL; Webster, R	1
Billot, L; Bompoint, S; Bots, ML; Cidambi, R; Field, J; Grobbee, DE; Patel, A; Poulter, N; Prabhakaran, D; Reddy, KS; Rodgers, A; Stanton, A; Thom, S	1
Billot, L; Bompoint, S; Brown, A; Burch, C; Burke, H; Cass, A; Hayman, N; Hillis, GS; Jan, S; Molanus, B; Neal, B; Patel, A; Peiris, D; Rafter, N; Reid, CM; Rodgers, A; Shiel, L; Togni, S; Tonkin, A; Usherwood, T; Webster, R	1
Bonham, L; Donnelly, RF; Hughes, CM; Quinn, HL	1
Bots, ML; Grobbee, DE; Lafeber, M; Patel, A; Prabhakaran, D; Rodgers, A; Spiering, W; Stanton, A; Thom, S; Visseren, FL; Webster, R	1
Boudoulas, KD; Taylor, M	1
Mehta, A; Sperling, LS; Wells, BJ	1
Attakora, J; Donkoh, IE; Ephraim, RKD; Essuman, G; Okyere, I; Okyere, P; Serwaa, D	1
Almaghaslah, D; Khaled, A; Makki, S; Nagib, R; Siddiqua, A	1

Reviews

2 review(s) available for aspirin and lisinopril

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Optimizing the treatment of heart failure. Current opinion in cardiology, 1994, Volume: 9 Suppl 1 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume	1994

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Optimizing the treatment of heart failure.

Current opinion in cardiology, 1994, Volume: 9 Suppl 1

Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume

1994

Trials

7 trial(s) available for aspirin and lisinopril

Article	Year
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function]. Zeitschrift fur Kardiologie, 1994, Volume: 83 Suppl 4 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation	1994
[Antihypertensive effect of enalapril and lisinopril administered in combination with nonsteroid anti-inflammatory agents]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:9 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Drug Antagonism; Enalapril; Female; Humans; Hypertension; Ibuprofen; Indomethacin; Lisinopril; Male; Middle Aged; Osteochondritis	2001
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization. Trials, 2011, Jan-05, Volume: 12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Attitude of Health Personnel; Biomarkers; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; Diuretics; Drug Combinations; Feasibility Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Assessment; Risk Factors; Simvastatin; Sri Lanka; Surveys and Questionnaires; Time Factors; Treatment Outcome; World Health Organization	2011
The evening versus morning polypill utilization study: the TEMPUS rationale and design. European journal of preventive cardiology, 2014, Volume: 21, Issue:4 Topics: Administration, Oral; Antihypertensive Agents; Aspirin; Biomarkers; Blood Platelets; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Clinical Protocols; Cross-Over Studies; Drug Chronotherapy; Drug Combinations; Dyslipidemias; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lisinopril; Netherlands; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Research Design; Simvastatin; Tablets; Time Factors; Treatment Outcome	2014
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA, 2013, Sep-04, Volume: 310, Issue:9 Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Female; Humans; Hydrochlorothiazide; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin; Treatment Outcome	2013
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European journal of preventive cardiology, 2015, Volume: 22, Issue:7 Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atenolol; Australia; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Drug Combinations; Drugs, Generic; Female; General Practice; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lisinopril; Male; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Primary Prevention; Prospective Studies; Risk Factors; Simvastatin; Sodium Chloride Symporter Inhibitors; Tablets; Time Factors; Treatment Outcome	2015
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk. European journal of preventive cardiology, 2017, Volume: 24, Issue:9 Topics: Administration, Oral; Aged; Antihypertensive Agents; Aspirin; Atenolol; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Drug Substitution; Europe; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome	2017

Other Studies

27 other study(ies) available for aspirin and lisinopril

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Angiotensin-converting enzyme inhibitors and renal function in heart failure. The American journal of cardiology, 1992, Oct-08, Volume: 70, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure; Captopril; Dipeptides; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Inulin; Kidney; Lisinopril; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Retrospective Studies	1992
Comment: angiotension-converting enzyme inhibitor hepatotoxicity: further insights. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Chemical and Drug Induced Liver Injury; Drug Interactions; Humans; Lisinopril; Male	1993
Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin. Die Pharmazie, 2002, Volume: 57, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Bradykinin; Female; Heart Ventricles; Lisinopril; Male; Mercaptoethanol; Methylene Blue; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Nitric Oxide; Prostaglandin Antagonists; Rats; Rats, Wistar; Signal Transduction	2002
Potential adverse interaction between aspirin and lisinopril in hypertensive rats. Human & experimental toxicology, 2003, Volume: 22, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Body Weight; Drug Antagonism; Hemodynamics; Hypertension; Kidney; Lisinopril; Male; Myocardium; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Survival Rate	2003
Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. European journal of heart failure, 2003, Volume: 5, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arteries; Aspirin; Blood Pressure; Chronic Disease; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diastole; Dose-Response Relationship, Drug; Enalapril; Endpoint Determination; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Manometry; Middle Aged; Observer Variation; Prospective Studies; Ramipril; Renin; Reproducibility of Results; Single-Blind Method; Systole; Thromboxane B2; Time Factors; Treatment Outcome	2003
Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. Pharmacological research, 2004, Volume: 49, Issue:1 Topics: Animals; Aspirin; Bradykinin; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Injections, Intravenous; Lisinopril; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Peptides; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazolium Salts	2004
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products. Journal of pharmaceutical and biomedical analysis, 2008, Jul-15, Volume: 47, Issue:3 Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization	2008
Polypill for the treatment of cardiovascular diseases part 2. LC-MS/TOF characterization of interaction/degradation products of atenolol/lisinopril and aspirin, and mechanisms of formation thereof. Journal of pharmaceutical and biomedical analysis, 2008, Nov-04, Volume: 48, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Cardiovascular Agents; Chromatography, Liquid; Drug Combinations; Drug Interactions; Lisinopril; Mass Spectrometry; Molecular Structure; Molecular Weight; Platelet Aggregation Inhibitors	2008
Late-appearing brachiocephalic aneurysm: an atypical vascular sequella of Kawasaki disease. Pediatric cardiology, 2009, Volume: 30, Issue:2 Topics: Acute Disease; Aneurysm; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Aspirin; Brachiocephalic Trunk; Child; Humans; Lisinopril; Magnetic Resonance Angiography; Male; Mucocutaneous Lymph Node Syndrome; Penicillins; Platelet Aggregation Inhibitors; Time Factors; Ultrasonography	2009
Wunderlich syndrome during antiplatelet drug therapy. Clinical nephrology, 2009, Volume: 71, Issue:3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Hematoma; Humans; Kidney Diseases; Leg; Lisinopril; Male; Tomography, X-Ray Computed	2009
Challenge. What is your diagnosis? Answer. Primary nodal diffuse large B-cell lymphoma with secondary cutaneous involvement. The American Journal of dermatopathology, 2009, Volume: 31, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Coronary Artery Disease; Diuretics; Exanthema; Humans; Hydrochlorothiazide; Lisinopril; Lymphoma, Large B-Cell, Diffuse; Male; Platelet Aggregation Inhibitors; Skin Neoplasms; Sotalol; Stents; Ticlopidine	2009
Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin? Harvard heart letter : from Harvard Medical School, 2011, Volume: 21, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Carbazoles; Carvedilol; Cholesterol, LDL; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Myocardial Infarction; Platelet Aggregation Inhibitors; Propanolamines	2011
Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs. Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:10 Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Aspirin; Atorvastatin; Cardiovascular Agents; Chemistry, Pharmaceutical; Drug Combinations; Drug Delivery Systems; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lisinopril; Microinjections; Platelet Aggregation Inhibitors; Swine	2015
24-year-old with history of smoking tobacco and cannabis · dyspnea · chest tightness. The Journal of family practice, 2018, Volume: 67, Issue:9 Topics: Adult; Antihypertensive Agents; Aspirin; Chest Pain; Coronary Vasospasm; Dyspnea; Humans; Lisinopril; Male; Marijuana Smoking; Metoprolol; Muscle Tonus; Rivaroxaban; Tobacco Smoking; Treatment Outcome; Young Adult	2018
Postexercise Ankle-Brachial Index Testing. JAMA, 2020, Aug-25, Volume: 324, Issue:8 Topics: Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Intermittent Claudication; Lisinopril; Middle Aged; Peripheral Arterial Disease	2020
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana. BMC nephrology, 2022, 10-26, Volume: 23, Issue:1 Topics: Adult; Aspirin; Bisoprolol; Conservative Treatment; Furosemide; Ghana; Humans; Irbesartan; Kidney Failure, Chronic; Lisinopril; Metformin; Middle Aged; Nifedipine; Ranitidine; Renal Replacement Therapy; Retrospective Studies; Sodium	2022
Detection and analysis of potential drug-drug interactions among patients admitted to the cardiac care unit in a tertiary care hospital. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:2 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Enoxaparin; Furosemide; Humans; Lisinopril; Ranitidine; Tertiary Care Centers	2023